AI-generated summary
The authors ran a randomized, double-blind, placebo-controlled trial comparing low-level laser therapy with placebo in patients with painful stomatitis from hand-foot-and-mouth disease. They report that the painful period was shorter in the laser group (4.0 days) than the placebo group (6.7 days), with the treatment judged acceptable for 90.0% of patients and no adverse events observed.
- Participants
- 20
- Who or what was studied
- Patients with hand-foot-and-mouth disease who had painful stomatitis (11 in the laser group, 9 in the placebo group)
- Wavelengths
- 830 nm
- Limits stated in the abstract
- The sample was small (20 patients), and the abstract does not describe a longer follow-up period or report results beyond the painful period.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journals.sagepub.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 830 nm
- Energy density (fluence)
- 1.1 J/cm2
- Power
- 30 mW
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Low-level laser therapy, Laser, Wavelength. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.